TRMB vs XENE · P/E 26, rev $1.91B vs $2.55B cap
Trimble Inc (TRMB) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported TRMB revenue for 2026-07-03 was $1.91B. Net income was -$372.8M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
TRMB currently screens at market cap $11.39B and trailing P/E 25.6. XENE currently screens at market cap $2.55B.
Not investment advice. Open the TRMB and XENE stock pages for the full models.
Not investment advice.